Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $82,609 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioFire Diagnostics, LLC | $79,341 | 5 | $0 (2023) |
| bioMerieux Inc | $3,268 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $79,341 | 5 | BioFire Diagnostics, LLC ($79,341) |
| 2022 | $3,268 | 2 | bioMerieux Inc ($3,268) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | BioFire Diagnostics, LLC | — | — | In-kind items and services | $2,438.25 | Research |
| 05/04/2023 | BioFire Diagnostics, LLC | — | — | In-kind items and services | $1,304.92 | Research |
| 02/28/2023 | BioFire Diagnostics, LLC | — | — | In-kind items and services | $2,124.00 | Research |
| 02/01/2023 | BioFire Diagnostics, LLC | — | — | In-kind items and services | $1,304.92 | Research |
| 01/31/2023 | BioFire Diagnostics, LLC | — | — | Cash or cash equivalent | $72,168.75 | Research |
| 08/25/2022 | bioMerieux Inc | — | — | Cash or cash equivalent | $1,960.74 | Research |
| Study: Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients and Clinical and Laboratory Features of Patients Diagnosed with Septic Arthritis | ||||||
| 06/23/2022 | bioMerieux Inc | — | — | Cash or cash equivalent | $1,307.16 | Research |
| Study: Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients and Clinical and Laboratory Features of Patients Diagnosed with Septic Arthritis | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients and Clinical and Laboratory Features of Patients Diagnosed with Septic Arthritis | bioMerieux Inc | $3,268 | 2 |
About Dr. Mark Steele, MD
Dr. Mark Steele, MD is a Emergency Medical Services healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790748259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Steele, MD has received a total of $82,609 in payments from pharmaceutical and medical device companies, with $79,341 received in 2023. These payments were reported across 7 transactions from 2 companies. The most common payment nature is "" ($82,609).
Practice Information
- Specialty Emergency Medical Services
- Location Kansas City, MO
- Active Since 04/07/2006
- Last Updated 11/08/2016
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1790748259
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medical Services Doctors in Kansas City
Thad Stephens, Md, MD
Emergency Medical Services — Payments: $11,975
Jeffrey Althoff, Md, MD
Emergency Medical Services — Payments: $1,999
Jeffrey Norvell, M.d, M.D
Emergency Medical Services — Payments: $358.52
Dr. Lynn Hill, Md, MD
Emergency Medical Services — Payments: $357.27
Dr. Thomas Millard, M.d, M.D
Emergency Medical Services — Payments: $148.48
Marc Larsen, Md, MD
Emergency Medical Services — Payments: $102.74